BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24313828)

  • 1. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.
    Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease.
    Miki Y; Tanji K; Mori F; Wakabayashi K
    Neurobiol Dis; 2015 Feb; 74():25-31. PubMed ID: 25449906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
    Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.
    Kon T; Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Feb; 34(1):19-26. PubMed ID: 23888880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases.
    Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
    Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.
    Luty AA; Kwok JB; Dobson-Stone C; Loy CT; Coupland KG; Karlström H; Sobow T; Tchorzewska J; Maruszak A; Barcikowska M; Panegyres PK; Zekanowski C; Brooks WS; Williams KL; Blair IP; Mather KA; Sachdev PS; Halliday GM; Schofield PR
    Ann Neurol; 2010 Nov; 68(5):639-49. PubMed ID: 21031579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease.
    Mori F; Tanji K; Miki Y; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2018 Jan; 662():389-394. PubMed ID: 29100804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
    Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K
    Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
    Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K
    Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases.
    Collins M; Li Y; Bowser R
    Acta Neuropathol Commun; 2020 Jun; 8(1):91. PubMed ID: 32586379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature of the nuclear inclusions formed by PQBP1, a protein linked to neurodegenerative polyglutamine diseases.
    Nicolaescu E; Beullens M; Lesage B; Keppens S; Himpens B; Bollen M
    Eur J Cell Biol; 2008 Oct; 87(10):817-29. PubMed ID: 18599155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
    Mori F; Tanji K; Odagiri S; Toyoshima Y; Yoshida M; Ikeda T; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2012 Jul; 124(1):149-51. PubMed ID: 22661321
    [No Abstract]   [Full Text] [Related]  

  • 13. Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.
    Gendron TF; Josephs KA; Petrucelli L
    Neuropathol Appl Neurobiol; 2010 Apr; 36(2):97-112. PubMed ID: 20202122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
    McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.
    Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP
    Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration.
    Bernard-Marissal N; Médard JJ; Azzedine H; Chrast R
    Brain; 2015 Apr; 138(Pt 4):875-90. PubMed ID: 25678561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy-related proteins (p62, NBR1 and LC3) in intranuclear inclusions in neurodegenerative diseases.
    Mori F; Tanji K; Odagiri S; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Aug; 522(2):134-8. PubMed ID: 22728060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis.
    Liu Y; Mimuro M; Yoshida M; Hashizume Y; Niwa H; Miyao S; Ujihira N; Akatsu H
    Acta Neuropathol; 2008 Dec; 116(6):615-23. PubMed ID: 18923837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress.
    Woulfe JM
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):2-42. PubMed ID: 17239006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance and limitation of the pathological classification of TDP-43 proteinopathy.
    Arai T
    Neuropathology; 2014 Dec; 34(6):578-88. PubMed ID: 25196969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.